|
Formation and Reverse Acquisition of Matinas BioPharma Holdings - Merger (Details Textual) (USD $)
|
1 Months Ended | |
|---|---|---|
|
May 31, 2013
|
Jul. 31, 2013
|
|
| Formation And Reverse Acquisition [Line Items] | ||
| Stock Issued During Period, Shares, New Issues | 7,500,000us-gaap_StockIssuedDuringPeriodSharesNewIssues | |
| Investment Warrants, Exercise Price | $ 2.00invest_InvestmentWarrantsExercisePrice | |
| Merger [Member] | ||
| Formation And Reverse Acquisition [Line Items] | ||
| Stock Issued During Period, Shares, New Issues |
9,000,000us-gaap_StockIssuedDuringPeriodSharesNewIssues / us-gaap_SubsidiarySaleOfStockAxis = mtnb_MergerMember |
|
| Aggregate Common Stock Holding Percentage |
28.50%mtnb_AggregateCommonStockHoldingPercentage / us-gaap_SubsidiarySaleOfStockAxis = mtnb_MergerMember |
|
| Warrants Issued For Purchase Of Common Stock |
1,000,000mtnb_WarrantsIsuuedForPurchaseOfCommonStock / us-gaap_SubsidiarySaleOfStockAxis = mtnb_MergerMember |
|
| Investment Warrants, Exercise Price |
$ 2.00invest_InvestmentWarrantsExercisePrice / us-gaap_SubsidiarySaleOfStockAxis = mtnb_MergerMember |
|
| X | ||||||||||
|
- Definition
Exercise price of the warrants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Represents the aggregate common stock holding percentage. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Represents the number of warrants issued for purchase of common stock during period. No definition available.
|
| X | ||||||||||
|
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|